GLPBio

Beta-secretase

Read More about this category

Beta-secretase (BACE) is an aspartic-acid protease important in the formation of myelin sheaths in peripheral nerve cells. The transmembrane protein contains two active site aspartate residues in its extracellular protein domain and may function as a dimer. Alzheimer's disease (AD) is caused by aggregates of the amyloid peptide (Abeta), which is generated by cleavage of the Abeta protein precursor (APP) by beta-secretase (BACE-1) followed by gamma-secretase. BACE-1 cleavage is limiting for the production of Abeta, Drugs to block this enzyme (BACE inhibitors) prevent the build up of beta-amyloid and may help slow or stop Alzheimers disease.

Products Related to Beta-secretase(27)

  • GA23320 structure
    GA23320OM99-2
    CAS: 314266-76-7
    Purity: >98%

    OM99-2, an eight-residue peptidomimetic, is a potent inhibitor of brain Memapsin 2 with a K i value of 9.58nM.

  • GC11098 structure
    GC11098Verubecestat (MK-8931)
    CAS: 1286770-55-5
    Purity: >99.50%

    Verubecestat (MK-8931) (MK-8931) is an orally active, high-affinity BACE1 and BACE2 inhibitor with Ki values of 2.2 nM and 0.38 nM.

  • GC13809 structure
    GC13809Eslicarbazepine acetate
    CAS: 236395-14-5
    Purity: >99.00%

    antiepileptic drug

  • GC14130 structure
    GC14130AZD3839
    CAS: 1227163-84-9
    Purity: >98.00%

    AZD3839 is a potent and selective orally active, brain-permeable BACE1 inhibitor (Ki=26 nM). AZD3839 shows 14 and >1000-fold selectivity against BACE2 and cathepsin D, respectively. AZD3839 exhibits dose- and time-dependent lowering of plasma, brain, and cerebrospinal fluid Aβ levels in mouse, guinea pig, and non-human primate. AZD3839 can be used for the research of Alzheimer's disease.

  • GC17227 structure
    GC17227LY2886721
    CAS: 1262036-50-9
    Purity: >99.50%

    BACE inhibitor

  • GC17791 structure
    GC17791LY2811376
    CAS: 1194044-20-6
    Purity: >99.50%

    A BACE1 inhibitor

  • GC18464 structure
    GC18464β-Secretase Inhibitor IV
    CAS: 797035-11-1
    Purity: >98.00%

    β-Secretase Inhibitor IV binds to the active site of BACE-1 and effectively blocks its proteolytic activity (IC₅₀=15nM).

  • GC19217 structure
    GC19217Lanabecestat
    CAS: 1383982-64-6
    Purity: >99.00%

    Lanabecestat (AZD3293) is a potent, highly permeable, orally active and blood-brain barrier penetrating BACE1 inhibitor with a Ki of 0.4 nM.

  • GC30199 structure
    GC30199BCA (Disodium bicinchoninate)
    CAS: 979-88-4
    Purity: >97.50%

    BCA (Disodium bicinchoninate) is a colorimetric reagent for the detection of copper.

  • GC30876 structure
    GC30876PF-06751979
    CAS: 1818339-66-0
    Purity: >99.00%

    PF-06751979 is a potent, brain penetrant, β-site amyloid precursor protein cleaving enzyme 1 (BACE1) inhibitor with an IC50 of 7.3 nM in BACE1 binding assay.

  • GC30884 structure
    GC30884LX2343
    CAS: 333745-53-2
    Purity: >99.50%

    An inhibitor of BACE1 and PI3K

  • GC31158 structure
    GC31158BACE1-IN-1
    CAS: 1310347-50-2
    Purity: >98%

    BACE1-IN-1 is a potent and highly brain penetrant BACE1 inhibitor with IC50s of 32 and 47 nM for human BACE1 and BACE2, respectively.

  • GC31260 structure
    GC31260BACE-IN-1
    CAS: 1254166-60-3
    Purity: >98%

    BACE-IN-1 (Compound 13) is a substituted lmidazo[1 ,2-a]pyridine derivative which can inhibit β-site amyloid precursor protein-cleaving enzyme (BACE) and that may be useful in the treatment of diseases in which BACE is involved, such as Alzheimer's disease.

  • GC33067 structure
    GC33067Sophoflavescenol
    CAS: 216450-65-6
    Purity: >98.00%

    Sophoflavescenol is a prenylated flavonol, which shows great inhibitory activity with IC50 of 0.013 μM against Phosphodiesterase 5 (PDE5), and also inhibits RLAR, HRAR, AGE, BACE1, AChE and BChE with IC50s of 0.30 ?M, 0.17 ?M, 17.89 ?g/mL, 10.98 ?M, 8.37 ?M and 8.21 ?M, respectively.

  • GC35299 structure
    GC35299Aloeresin D
    CAS: 105317-67-7
    Purity: >98%

    Aloeresin D is a chromone glycoside isolated from Aloe vera, inhibits β-Secretase (BACE1) activity, with an IC50 of 39 μM.

  • GC35455 structure
    GC35455BACE1-IN-4
    CAS: 2361157-92-6
    Purity: >98%

    BACE1-IN-4 is a potent and highly selective BACE1 inhibitor, with an IC50 of 3.8 nM and a Ki of 1.9 nM, more selective at BACE1 over BACE2.

  • GC35996 structure
    GC35996Epiberberine chloride
    CAS: 889665-86-5
    Purity: >99.50%

    Epiberberine chloride is an alkaloid isolated from Coptis chinensis, acts as a potent AChE and BChE inhibitor, and a non-competitive BACE1 inhibitor, with IC50s of 1.07, 6.03 and 8.55 μM, respectively.

  • GC36145 structure
    GC36145Glabrolide
    CAS: 10401-33-9
    Purity: >98%

    Glabrolide, derived from Glycyrrhiza uralensis Fisch.

  • GC38489 structure
    GC38489(1α,1'S,4β)-Lanabecestat
    CAS: 1384082-96-5
    Purity: >98%

    (1α,1'S,4β)-Lanabecestat ((1α,1'S,4β)-AZD3293) a less active enantiomer of Lanabecestat.

  • GC39798 structure
    GC39798Scoulerine
    CAS: 6451-73-6
    Purity: >99.00%

    Scoulerine ((-)-Scoulerine), an isoquinoline alkaloid, is a potent antimitotic compound. Scoulerine is also an inhibitor of BACE1 (?-site amyloid precursor protein cleaving enzyme 1). Scoulerine inhibits proliferation, arrests cell cycle, and induces apoptosis in cancer cells.

  • GC50672 structure
    GC50672LY 2886721 Hydrochloride
    CAS: 1262036-49-6
    Purity: >98.00%
  • GC64554 structure
    GC64554Aloenin
    CAS: 38412-46-3
    Purity: >98%

    Aloenin (Aloenin A) is a natural compound, which has potent peroxyl radical-scavenging activities and moderate inhibitory active on β-secretase (BACE).

  • GC64967 structure
    GC64967Elenbecestat
    CAS: 1388651-30-6
    Purity: >99.00%

    Elenbecestat (E2609) is a potent, orally bioavailable and CNS-penetrant BACE-1 inhibitor.

  • GC65361 structure
    GC65361Umibecestat
    CAS: 1387560-01-1
    Purity: >99.00%

    Umibecestat (CNP520) is a beta-site amyloid precursor protein cleaving enzyme-1 (BACE-1) inhibitor with IC50s of 11 nM and 10 nM for human BACE-1 and mouse BACE-1, respectively.